找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Coronary Artery Disease: Therapeutics and Drug Discovery; Miao Wang Book 2020 Springer Nature Singapore Pte Ltd. 2020 coronary artery dise

[復制鏈接]
樓主: controllers
21#
發(fā)表于 2025-3-25 04:36:39 | 只看該作者
Malnutrition in Captive Birds of Preyure as well as those that prevent heart failure progression, in each category major clinical trials are also described. In addition, information about some of potential new drugs are also mentioned. Traditional Chinese medicine also shows its potential in treating HF, and we are still lack of medicine to treat HFpEF.
22#
發(fā)表于 2025-3-25 09:48:42 | 只看該作者
23#
發(fā)表于 2025-3-25 11:59:11 | 只看該作者
Pharmaceutical Treatment for Heart Failure,ure as well as those that prevent heart failure progression, in each category major clinical trials are also described. In addition, information about some of potential new drugs are also mentioned. Traditional Chinese medicine also shows its potential in treating HF, and we are still lack of medicine to treat HFpEF.
24#
發(fā)表于 2025-3-25 18:24:56 | 只看該作者
Book 2020e. It highlights drug pharmacology and therapeutic challenges, with a special emphasis on the underlying principles of available therapeutics and the on-going development of drugs for coronary artery disease..The book is divided into eight chapters, the first of which describes the classical mechani
25#
發(fā)表于 2025-3-25 21:55:16 | 只看該作者
26#
發(fā)表于 2025-3-26 02:00:34 | 只看該作者
A. Aeschlimann,C. Mermod,J. F. Graf need. In this chapter, we provide an overview on the pathophysiology of thrombosis, followed by introduction of each class of antithrombotic drugs including their pharmacology, clinical applications and limitations. Practical challenges and future perspectives of antithrombotic drugs are discussed in the last part of this chapter.
27#
發(fā)表于 2025-3-26 06:00:32 | 只看該作者
28#
發(fā)表于 2025-3-26 09:56:28 | 只看該作者
29#
發(fā)表于 2025-3-26 13:55:14 | 只看該作者
30#
發(fā)表于 2025-3-26 18:54:49 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 11:20
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
铅山县| 亳州市| 湟中县| 汤阴县| 宁明县| 静宁县| 新泰市| 阜新市| 延庆县| 沅江市| 新绛县| 和田县| 常德市| 红桥区| 富宁县| 辰溪县| 延长县| 闽侯县| 镇巴县| 宁德市| 灵山县| 木里| 许昌市| 奎屯市| 霞浦县| 中方县| 三台县| 皮山县| 武强县| 保靖县| 襄城县| 远安县| 米林县| 锦州市| 瑞昌市| 鄱阳县| 赣榆县| 梧州市| 贞丰县| 礼泉县| 民勤县|